NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Peripheral Neuropathy
Interventions: DRUG: Placebo|DRUG: NBP Softgel Capsules
Sponsor: Conjupro Biotherapeutics, Inc.
Collaborators: CSPC-NBP Pharmaceutical Co., Ltd.